{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:57:59Z","timestamp":1788562679938,"version":"build-2803163510"},"reference-count":89,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National institutes of Health","award":["R01AG061038"],"award-info":[{"award-number":["R01AG061038"]}]},{"name":"National institutes of Health","award":["R01AG071682"],"award-info":[{"award-number":["R01AG071682"]}]},{"name":"National institutes of Health","award":["P30AG072973"],"award-info":[{"award-number":["P30AG072973"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Apolipoprotein E4 (ApoE4) is the most recognized genetic risk factor for late-onset Alzheimer\u2019s disease (LOAD), whereas ApoE2 reduces the risk for LOAD. The underlying mechanisms are unclear but may include effects on brain energy metabolism. Here, we used neuro-2a (N2a) cells that stably express human ApoE isoforms (N2a-hApoE), differentiated N2a-hApoE neuronal cells, and humanized ApoE knock-in mouse models to investigate relationships among ApoE isoforms, glycolytic metabolism, and neuronal health and aging. ApoE2-expressing cells retained robust hexokinase (HK) expression and glycolytic activity, whereas these endpoints progressively declined with aging in ApoE4-expressing cells. These divergent ApoE2 and ApoE4 effects on glycolysis directly correlated with markers of cellular wellness. Moreover, ApoE4-expressing cells upregulated phosphofructokinase and pyruvate kinase with the apparent intent of compensating for the HK-dependent glycolysis reduction. The introduction of ApoE2 increased HK levels and glycolysis flux in ApoE4 cells. PI3K\/Akt signaling was distinctively regulated by ApoE isoforms but was only partially responsible for the ApoE-mediated effects on HK. Collectively, our findings indicate that human ApoE isoforms differentially modulate neuronal glycolysis through HK regulation, with ApoE2 upregulating and ApoE4 downregulating, which markedly impacts neuronal health during aging. These findings lend compelling support to the emerging inverse-Warburg theory of AD and highlight a therapeutic opportunity for bolstering brain glycolytic resilience to prevent and treat AD.<\/jats:p>","DOI":"10.3390\/cells12030410","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T01:57:07Z","timestamp":1674698227000},"page":"410","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Opposing Effects of ApoE2 and ApoE4 on Glycolytic Metabolism in Neuronal Aging Supports a Warburg Neuroprotective Cascade against Alzheimer\u2019s Disease"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8525-3597","authenticated-orcid":false,"given":"Xin","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, School of Pharmacy, University of Kansas, Lawrence, KS 66045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1165-1784","authenticated-orcid":false,"given":"Long","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, School of Pharmacy, University of Kansas, Lawrence, KS 66045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell H.","family":"Swerdlow","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Kansas Medical Center, Kansas City, KS 66160, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, School of Pharmacy, University of Kansas, Lawrence, KS 66045, USA"},{"name":"Neuroscience Graduate Program, University of Kansas, Lawrence, KS 66045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neuron.2012.11.020","article-title":"Apolipoprotein e sets the stage: Response to injury triggers neuropathology","volume":"76","author":"Mahley","year":"2012","journal-title":"Neuron"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","article-title":"Apolipoprotein E: Far more than a lipid transport protein","volume":"1","author":"Mahley","year":"2000","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat Rev. Neurol."},{"key":"ref_4","unstructured":"Alzheimer\u2019s Association (2021). 2020 Alzheimer\u2019s Disease Facts and Figures. Alzheimers Dement., 17, 391."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0304-3940(94)12126-B","article-title":"Effect of apolipoprotein E genotype on Alzheimer\u2019s disease neuropathology in a cohort of elderly Norwegians","volume":"201","author":"Morris","year":"1995","journal-title":"Neurosci. Lett."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0306-4522(95)00331-C","article-title":"Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer\u2019s disease","volume":"69","author":"Nagy","year":"1995","journal-title":"Neuroscience"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/jnnp.73.6.672","article-title":"The apolipoprotein E epsilon 2 allele and decline in episodic memory","volume":"73","author":"Wilson","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.neurobiolaging.2006.12.008","article-title":"Hippocampal hypometabolism predicts cognitive decline from normal aging","volume":"29","author":"Mosconi","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.bbadis.2013.09.010","article-title":"The Alzheimer\u2019s disease mitochondrial cascade hypothesis: Progress and perspectives","volume":"1842","author":"Swerdlow","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00000441-199409000-00003","article-title":"Brain glucose metabolism in Alzheimer\u2019s disease","volume":"308","author":"Swerdlow","year":"1994","journal-title":"Am. J. Med. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/bs.irn.2020.02.002","article-title":"Chapter Five\u2014APOE and metabolic dysfunction in Alzheimer\u2019s disease","volume":"Volume 154","author":"Esterline","year":"2020","journal-title":"International Review of Neurobiology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jalz.2017.09.011","article-title":"Evidence for brain glucose dysregulation in Alzheimer\u2019s disease","volume":"14","author":"An","year":"2018","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neurobiolaging.2018.03.014","article-title":"Aerobic glycolysis and tau deposition in preclinical Alzheimer\u2019s disease","volume":"67","author":"Vlassenko","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e12924","DOI":"10.1111\/acel.12924","article-title":"Systems biology identifies preserved integrity but impaired metabolism of mitochondria due to a glycolytic defect in Alzheimer\u2019s disease neurons","volume":"18","author":"Theurey","year":"2019","journal-title":"Aging Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"662242","DOI":"10.3389\/fnins.2021.662242","article-title":"Glycolytic Metabolism, Brain Resilience, and Alzheimer\u2019s Disease","volume":"15","author":"Zhang","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Newington, J.T., Pitts, A., Chien, A., Arseneault, R., Schubert, D., and Cumming, R.C. (2011). Amyloid beta resistance in nerve cell lines is mediated by the Warburg effect. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0019191"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.biopsych.2007.05.030","article-title":"Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints","volume":"63","author":"Mosconi","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJM199603213341202","article-title":"Preclinical evidence of Alzheimer\u2019s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E","volume":"334","author":"Reiman","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"0389-18.2019","DOI":"10.1523\/ENEURO.0389-18.2019","article-title":"Aerobic Glycolysis Is Required for Spatial Memory Acquisition But Not Memory Retrieval in Mice","volume":"6","author":"Harris","year":"2019","journal-title":"Eneuro"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1523\/JNEUROSCI.2262-17.2018","article-title":"Human ApoE Isoforms Differentially Modulate Brain Glucose and Ketone Body Metabolism: Implications for Alzheimer\u2019s Disease Risk Reduction and Early Intervention","volume":"38","author":"Wu","year":"2018","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_21","unstructured":"Wu, L. (2017). Perturbed Brain Energy Metabolism in Alzheimer\u2019s Disease and Diabetes. [Ph.D. Thesis, University of Kansas]. Available online: https:\/\/kuscholarworks.ku.edu\/handle\/1808\/25391."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jneumeth.2009.11.004","article-title":"Differentiation of mouse Neuro 2A cells into dopamine neurons","volume":"186","author":"Tremblay","year":"2010","journal-title":"J. Neurosci. Methods"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cellsig.2009.01.036","article-title":"Functional decreases in P2X7 receptors are associated with retinoic acid-induced neuronal differentiation of Neuro-2a neuroblastoma cells","volume":"21","author":"Wu","year":"2009","journal-title":"Cell. Signal."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.neuroscience.2003.10.011","article-title":"Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice","volume":"124","author":"Sullivan","year":"2004","journal-title":"Neuroscience"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13024-017-0231-7","article-title":"Practical considerations for choosing a mouse model of Alzheimer\u2019s disease","volume":"12","author":"Jankowsky","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ding, F., Yao, J., Rettberg, J.R., Chen, S., and Brinton, R.D. (2013). Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer\u2019s mouse brain: Implication for bioenergetic intervention. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0079977"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/309467a0","article-title":"Evolution of phosphofructokinase\u2014Gene duplication and creation of new effector sites","volume":"309","author":"Poorman","year":"1984","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1042\/BCJ20200656","article-title":"Biochemical and transcript level differences between the three human phosphofructokinases show optimisation of each isoform for specific metabolic niches","volume":"477","author":"Fernandes","year":"2020","journal-title":"Biochem. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/cdd.2016.36","article-title":"Metabolic reprogramming during neuronal differentiation","volume":"23","author":"Agostini","year":"2016","journal-title":"Cell Death Differ."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1432-1033.1973.tb02969.x","article-title":"Pyruvate Kinase","volume":"37","author":"Carbonell","year":"1973","journal-title":"Eur. J. Biochem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.neuron.2015.03.035","article-title":"A cellular perspective on brain energy metabolism and functional imaging","volume":"86","author":"Magistretti","year":"2015","journal-title":"Neuron"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3233\/JAD-160841","article-title":"Glucose Transporters in Brain: In Health and in Alzheimer\u2019s Disease","volume":"55","author":"Szablewski","year":"2017","journal-title":"J. Alzheimers Dis. JAD"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1523\/JNEUROSCI.2994-18.2019","article-title":"Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer\u2019s Disease Risk","volume":"39","author":"Huang","year":"2019","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/bbrc.2002.6586","article-title":"Apolipoprotein E activates Akt pathway in neuro-2a in an isoform-specific manner","volume":"292","author":"Laffont","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/cdd.2014.173","article-title":"Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy","volume":"22","author":"Roberts","year":"2015","journal-title":"Cell Death Differ."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1523\/JNEUROSCI.1972-08.2008","article-title":"Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels","volume":"28","author":"Riddell","year":"2008","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/ars.2009.2887","article-title":"Protein carbonylation","volume":"12","author":"Suzuki","year":"2010","journal-title":"Antioxid. Redox. Signal."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13024-020-00413-4","article-title":"APOE2: Protective mechanism and therapeutic implications for Alzheimer\u2019s disease","volume":"15","author":"Li","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1212\/01.WNL.0000148478.39691.D3","article-title":"Cerebral glucose metabolism in patients with AD and different APOE Genotypes","volume":"64","author":"Drzezga","year":"2005","journal-title":"Neurology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-005-1762-7","article-title":"Brain glucose metabolism in the early and specific diagnosis of Alzheimer\u2019s disease","volume":"32","author":"Mosconi","year":"2005","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cmet.2013.11.020","article-title":"Aerobic glycolysis in the human brain is associated with development and neotenous gene expression","volume":"19","author":"Goyal","year":"2014","journal-title":"Cell Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1242\/jeb.172.1.171","article-title":"The role of V-ATPase in neuronal and endocrine systems","volume":"172","author":"Moriyama","year":"1992","journal-title":"J. Exp. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.virol.2013.06.026","article-title":"Glycolytic control of vacuolar-type ATPase activity: A mechanism to regulate influenza viral infection","volume":"444","author":"Kohio","year":"2013","journal-title":"Virology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"C97","DOI":"10.1152\/ajpcell.00469.2003","article-title":"Glucose activates H+-ATPase in kidney epithelial cells","volume":"287","author":"Nakamura","year":"2004","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3233\/JAD-160307","article-title":"Human ApoE \u025b2 Promotes Regulatory Mechanisms of Bioenergetic and Synaptic Function in Female Brain: A Focus on V-type H +-ATPase","volume":"53","author":"Woody","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e15230","DOI":"10.1371\/journal.pone.0015230","article-title":"Amyloid-\u03b2 triggers the release of neuronal hexokinase 1 from mitochondria","volume":"5","author":"Saraiva","year":"2010","journal-title":"PLoS ONE"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0304-3940(90)90138-Y","article-title":"Altered hexokinase activity in skin cultured fibroblasts and leukocytes from Alzheimer\u2019s disease patients","volume":"117","author":"Sorbi","year":"1990","journal-title":"Neurosci. Lett."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1046\/j.1471-4159.1996.67031164.x","article-title":"Changes of Activity and Isozyme Pattern of Phosphofructokinase in the Brains of Patients with Alzheimer\u2019s Disease","volume":"67","author":"Bigl","year":"1996","journal-title":"J. Neurochem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s007020050174","article-title":"Activities of key glycolytic enzymes in the brains of patients with Alzheimer\u2019s disease","volume":"106","author":"Bigl","year":"1999","journal-title":"J. Neural Transm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e0116092","DOI":"10.1371\/journal.pone.0116092","article-title":"Upregulation of glycolytic enzymes, mitochondrial dysfunction and increased cytotoxicity in glial cells treated with Alzheimer\u2019s disease plasma","volume":"10","author":"Jayasena","year":"2015","journal-title":"PLoS ONE"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuron.2017.09.003","article-title":"Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes","volume":"96","author":"Zhao","year":"2017","journal-title":"Neuron"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3233\/JAD-181184","article-title":"Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function","volume":"68","author":"Orr","year":"2019","journal-title":"J. Alzheimers Dis. JAD"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"104742","DOI":"10.1016\/j.nbd.2020.104742","article-title":"APOE alters glucose flux through central carbon pathways in astrocytes","volume":"136","author":"Williams","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13024-021-00483-y","article-title":"APO\u03954 lowers energy expenditure in females and impairs glucose oxidation by increasing flux through aerobic glycolysis","volume":"16","author":"Farmer","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"108572","DOI":"10.1016\/j.celrep.2020.108572","article-title":"ApoE4 Impairs Neuron-Astrocyte Coupling of Fatty Acid Metabolism","volume":"34","author":"Qi","year":"2021","journal-title":"Cell Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"10625","DOI":"10.1073\/pnas.91.22.10625","article-title":"Glutamate uptake into astrocytes stimulates aerobic glycolysis: A mechanism coupling neuronal activity to glucose utilization","volume":"91","author":"Pellerin","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.stemcr.2019.08.004","article-title":"PSEN1\u0394E9, APPswe, and APOE4 Confer Disparate Phenotypes in Human iPSC-Derived Microglia","volume":"13","author":"Konttinen","year":"2019","journal-title":"Stem Cell Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41398-021-01631-0","article-title":"APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline","volume":"11","author":"Fang","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Li, J.-M., Liu, C., Hu, X., Cai, Y., Ma, C., Luo, X.-G., and Yan, X.-X. (2014). Inverse correlation between Alzheimer\u2019s disease and cancer: Implication for a strong impact of regenerative propensity on neurodegeneration?. BMC Neurol., 14.","DOI":"10.1186\/s12883-014-0211-2"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41380-020-0760-2","article-title":"Cancer and Alzheimer\u2019s disease inverse relationship: An age-associated diverging derailment of shared pathways","volume":"26","author":"Lanni","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"(2013). Skin cancer\u2014Protective effect against Alzheimer disease?. Nat. Rev. Neurol., 9, 358.","DOI":"10.1038\/nrneurol.2013.113"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"(2015). Alzheimer\u2019s role of breast-cancer gene. Nature, 528, 10.","DOI":"10.1038\/528010c"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/nrneurol.2010.7","article-title":"Cancer link to Alzheimer disease, but not vascular dementia","volume":"6","author":"Beal","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fnins.2019.00155","article-title":"Alzheimer\u2019s Disease and Cancer: When Two Monsters Cannot Be Together","volume":"13","author":"Majd","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg\u2019s contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_66","first-page":"522","article-title":"Alzheimer\u2019s disease: The amyloid hypothesis and the Inverse Warburg effect","volume":"5","author":"Demetrius","year":"2014","journal-title":"Front. Physiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10522-012-9403-6","article-title":"An inverse-Warburg effect and the origin of Alzheimer\u2019s disease","volume":"13","author":"Demetrius","year":"2012","journal-title":"Biogerontology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1002\/jcp.25998","article-title":"Involvement of the Warburg effect in non-tumor diseases processes","volume":"233","author":"Chen","year":"2018","journal-title":"J. Cell Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10522-017-9692-x","article-title":"A disease with a sweet tooth: Exploring the Warburg effect in Alzheimer\u2019s disease","volume":"18","author":"Atlante","year":"2017","journal-title":"Biogerontology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13195-022-01004-9","article-title":"Cerebrospinal fluid lactate levels along the Alzheimer\u2019s disease continuum and associations with blood-brain barrier integrity, age, cognition, and biomarkers","volume":"14","author":"Zebhauser","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s007020050161","article-title":"The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer\u2019s disease","volume":"106","author":"Palmer","year":"1999","journal-title":"J. Neural. Transm."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/10715760701861373","article-title":"Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer\u2019s disease from Mild Cognitive Impairment","volume":"42","author":"Bermejo","year":"2008","journal-title":"Free Radic. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/jcbfm.2013.222","article-title":"Glycolysis and oxidative phosphorylation in neurons and astrocytes during network activity in hippocampal slices","volume":"34","author":"Ivanov","year":"2014","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/brain\/awp099","article-title":"Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer\u2019s disease","volume":"132","author":"Liu","year":"2009","journal-title":"Brain"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"648617","DOI":"10.3389\/fnins.2021.648617","article-title":"Sialometabolism in Brain Health and Alzheimer\u2019s Disease","volume":"15","author":"Rawal","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"105631","DOI":"10.1016\/j.nbd.2022.105631","article-title":"Human apolipoprotein E isoforms are differentially sialylated and the sialic acid moiety in ApoE2 attenuates ApoE2-A\u03b2 interaction and A\u03b2 fibrillation","volume":"164","author":"Moon","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1038\/sj.onc.1209595","article-title":"Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt","volume":"25","author":"Robey","year":"2006","journal-title":"Oncogene"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1074\/jbc.M109950200","article-title":"Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis","volume":"277","author":"Pastorino","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Chiara, F., Castellaro, D., Marin, O., Petronilli, V., Brusilow, W.S., Juhaszova, M., Sollott, S.J., Forte, M., Bernardi, P., and Rasola, A. (2008). Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0001852"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"13482","DOI":"10.1074\/jbc.M708216200","article-title":"Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: Mapping the site of binding","volume":"283","author":"Zaid","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/cvr\/cvr302","article-title":"The mPTP and its regulatory proteins: Final common targets of signalling pathways for protection against necrosis","volume":"94","author":"Miura","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"39846","DOI":"10.1074\/jbc.M403835200","article-title":"Mitochondrial bound hexokinase activity as a preventive antioxidant defense: Steady-state ADP formation as a regulatory mechanism of membrane potential and reactive oxygen species generation in mitochondria","volume":"279","author":"Oliveira","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"154227","DOI":"10.1016\/j.metabol.2020.154227","article-title":"Role of apolipoprotein E in electronegative low-density lipoprotein-induced mitochondrial dysfunction in cardiomyocytes","volume":"107","author":"Chen","year":"2020","journal-title":"Metabolism"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2016.04.020","article-title":"Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer\u2019s disease mouse models","volume":"44","author":"Zhao","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"212ra161","DOI":"10.1126\/scitranslmed.3007000","article-title":"Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain","volume":"5","author":"Hudry","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1007\/s12035-017-0757-2","article-title":"Transcriptional Effects of ApoE4: Relevance to Alzheimer\u2019s Disease","volume":"55","author":"Theendakara","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jalz.2017.07.754","article-title":"Apolipoprotein E4 inhibits autophagy gene products through direct, specific binding to CLEAR motifs","volume":"14","author":"Parcon","year":"2018","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s12264-020-00490-x","article-title":"Altered Energy Metabolism During Early Optic Nerve Crush Injury: Implications of Warburg-Like Aerobic Glycolysis in Facilitating Retinal Ganglion Cell Survival","volume":"36","author":"Zhu","year":"2020","journal-title":"Neurosci. Bull."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/3\/410\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:15:22Z","timestamp":1760120122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/3\/410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":89,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["cells12030410"],"URL":"https:\/\/doi.org\/10.3390\/cells12030410","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,25]]}}}